Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-10-2012 | Poster presentation

Hemozoin impairs cell cycle progression and promotes chemokine release in human microvascular endothelial cells

Authors: Nicoletta Basilico, Daniela Girelli, Sarah D’Alessandro, Yolanda Corbett, Mauro Prato, Silvia Carluccio, Serena Del Bue, Pasquale Ferrante, Donatella Taramelli

Published in: Malaria Journal | Special Issue 1/2012

Login to get access

Excerpt

Cerebral malaria (CM) is a fatal complication of P.falciparum infection caused by the cytoadherence of infected erythrocytes to brain endothelial cells followed by micro-circulatory obstruction, blood-brain barrier (BBB) damage, ring hemorrhages, inflammatory response and neurological sequelae. The combination of both parasite and host factors are involved in the pathogenesis of CM. In particular, malarial pigment, hemozoin (HZ) was shown to interfere with monocytes and endothelial cell functions. Recently our group demonstrated that HZ enhanced total gelatinolytic activity in endothelial cells by inducing ex novo matrix metalloproteinases-9 (MMP-9) and promoting proMMP-9 protein expression (Prato et al., 2011). …
Metadata
Title
Hemozoin impairs cell cycle progression and promotes chemokine release in human microvascular endothelial cells
Authors
Nicoletta Basilico
Daniela Girelli
Sarah D’Alessandro
Yolanda Corbett
Mauro Prato
Silvia Carluccio
Serena Del Bue
Pasquale Ferrante
Donatella Taramelli
Publication date
01-10-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-S1-P9

Other articles of this Special Issue 1/2012

Malaria Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.